Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000647160 | SCV000768947 | benign | Dilated cardiomyopathy 1DD | 2024-02-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002422357 | SCV002730379 | uncertain significance | Cardiovascular phenotype | 2022-05-03 | criteria provided, single submitter | clinical testing | The p.K700N variant (also known as c.2100G>C), located in coding exon 9 of the RBM20 gene, results from a G to C substitution at nucleotide position 2100. The lysine at codon 700 is replaced by asparagine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV000647160 | SCV002775676 | uncertain significance | Dilated cardiomyopathy 1DD | 2021-09-14 | criteria provided, single submitter | clinical testing |